TWi Pharmaceuticals Inc (安成藥業) yesterday said that it would go private after chairman Chen Chih-ming (陳志明) spent NT$2.63 billion (US$85.3 million) acquiring 36.52 million, or 30.34 percent, of its issued shares.
Chen successfully acquired TWi through a public tender offer, with the minimum purchase set at 5 percent of TWi’s issued shares, company spokeswomen Angela Luan (欒君儀) told a news conference in Taipei.
Chen already owned a 56.43 percent stake in the firm, together with other affiliated parties, and now his TWi holdings have increased to 86.77 percent, Luan said.
TWi’s board of directors yesterday approved a share swap with Calchen Pharmaceuticals Inc (加陳國際藥業), a private firm held by Chen, at an exchange ratio of one-to-one, she said, adding that the share swap would begin on Aug. 5.
If the stock swap is approved at a general shareholders’ meeting on June 21, TWi would apply to the Taipei Exchange and the Financial Supervisory Commission to be delisted from the local bourse, Luan said.
“After the stock swap, Calchen would own 100 percent of its shares, making TWi its wholly owned subsidiary,” she said.
“TWi will belong to Calchen and continue its operations. So, if investors believe in us, trusting that we will make a good profit, they can hold onto their shares and watch how Calchen performs,” Luan said.
If shareholders choose to cash out, they could sell their TWi shares to the firm directly at the shareholders’ meeting in June, for a negotiable price, or later sell their Calchen shares to Calchen at NT$72 per share, she said.
The offer of NT$72 per share is much lower than TWi’s initial public offering price of NT$248 in 2013, as the company’s share prices have fallen in recent years.
Some minority shareholders reportedly criticized the firm for sending a pessimistic message last month, before Chen announced his bid, dragging the stock lower.
Luan said that TWi reported lower-than-expected revenue due to intense market competition, with share prices averaging NT$60 last year.
The stock was suspended for trading yesterday and closed at NT$70.3 on Thursday.
“Investors will always be unsatisfied no matter how much the tender offer price is, but we will leave society to judge whether NT$72 per share is fair,” Luan said.
Shares of contract chipmaker Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) came under pressure yesterday after a report that Apple Inc is looking to shift some orders from the Taiwanese company to Intel Corp. TSMC shares fell NT$55, or 2.4 percent, to close at NT$2,235 on the local main board, Taiwan Stock Exchange data showed. Despite the losses, TSMC is expected to continue to benefit from sound fundamentals, as it maintains a lead over its peers in high-end process development, analysts said. “The selling was a knee-jerk reaction to an Intel-Apple report over the weekend,” Mega International Investment Services Corp (兆豐國際投顧) analyst Alex Huang
Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) is expected to remain Apple Inc’s primary chip manufacturing partner despite reports that Apple could shift some orders to Intel Corp, industry experts said yesterday. The comments came after The Wall Street Journal reported on Friday that Apple and Intel had reached a preliminary agreement following more than a year of negotiations for Intel to manufacture some chips for Apple devices. Taiwan Institute of Economic Research (台灣經濟研究院) economist Arisa Liu (劉佩真) said TSMC’s advanced packaging technologies, including integrated fan-out and chip-on-wafer-on-substrate, remain critical to the performance of Apple’s A-series and M-series chips. She said Intel and Samsung
TRANSITION: With the closure, the company would reorganize its Taiwanese unit to a sales and service-focused model, Bridgestone said Bridgestone Corp yesterday announced it would cease manufacturing operations at its tire plant in Hsinchu County’s Hukou Township (湖口), affecting more than 500 workers. Bridgestone Taiwan Co (台灣普利司通) said in a statement that the decision was based on the Tokyo-based tire maker’s adjustments to its global operational strategy and long-term market development considerations. The Taiwanese unit would be reorganized as part of the closure, effective yesterday, and all related production activities would be concluded, the statement said. Under the plan, Bridgestone would continue to deepen its presence in the Taiwanese market, while transitioning to a sales and service-focused business model, it added. The Hsinchu
Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) has approved a capital budget of US$31.28 billion for production expansion to meet long-term development needs during the artificial intelligence (AI) boom. The company’s board meeting yesterday approved the capital appropriation plan for purposes such as the installation of advanced technology capacity and fab construction, the world’s largest contract chipmaker said in a statement. At an earnings conference last month, TSMC forecast that its capital expenditure for this year would be at the higher end of the US$52 billion to US$56 billion range it forecast in January in response to robust demand for 5G, AI and
RSS